Trials / Recruiting
RecruitingNCT05014399
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Joseph McCollom · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.
Conditions
- Neoplasm, Colorectal
- Cognitive Impairment
- Cognitive Dysfunction
- Cognitive Change
- Chemo-brain
- Chemo Fog
- Chemotherapy Effect
- Cognitive Decline
Timeline
- Start date
- 2021-09-20
- Primary completion
- 2026-10-01
- Completion
- 2031-10-01
- First posted
- 2021-08-20
- Last updated
- 2025-06-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05014399. Inclusion in this directory is not an endorsement.